Institutionally Limited & Time-Sensitive Opportunities
Greetings,
Please see below our weekly digest of new limited submissions and time-sensitive opportunities.
This Week’s Announcements:
- New Nominations
- New Limited Submissions
- Other Funding Opportunities of Note
New Nominations:
- Congratulations to Lamis Naddaf (Keck) and Bojung Seo (Keck) for their nominations to PAR-23-286: NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Not Allowed).
- Congratulations to Maryam Shanechi (Viterbi) for her nomination to the Physical Sciences & Engineering track of the Blavatnik Awards for Young Scientists.
- RII wishes our nominees the best of luck!
New Limited Submissions:
- Please find below one limited submission for your perusal and distribution. A link to the opportunity is below:
- Process for Limited Submissions: PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure Application Portal: https://rii.usc.edu/oor-portal/. PIs must create their own SurveyMonkey account in order to proceed with submission. Materials to submit include:
- (1) Two-Page Proposal Summary (1” margins; single-spaced; font type: Arial, Helvetica, Times New Roman, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 2-page limit will be excluded from review.
- (2) CV – (5 pages maximum)
- Note: The portal requires information about the PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.
- (1) Two-Page Proposal Summary (1” margins; single-spaced; font type: Arial, Helvetica, Times New Roman, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 2-page limit will be excluded from review.
Other Opportunities of Note:
- The Water Foundation’s Safe Clean Water Program has announced that the deadline to submit a proposal for Round 2 is January 31, 2025, and the final submission deadline for the program is May 31, 2025.
- As always, reach out to SCWquestions@waterfdn.org (cc’d) with any questions.
- For more information, visit the link here: https://waterfdn.org/safe-clean-water-program/.
- Please contact Jennifer Lidar in Foundation Relations at jlidar@usc.edu if you are interested in applying.
- Please contact Jennifer Lidar in Foundation Relations at jlidar@usc.edu if you are interested in applying.
- The Gates Foundation and LifeArc* have launched a joint Grand Challenges request for proposals, “Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing”.
- Monoclonal antibodies are one of the most powerful tools in modern medicine. They are highly specific, safe, and effective medicines for a range of conditions, including treating non-communicable diseases and preventing and treating infectious diseases. These biologic therapies already save lives and improve the quality of life for many millions of patients, but high production costs continue to limit access to mAbs, especially for patients in low- and middle-income settings. While there are indication-specific dosage requirements for mAbs, it is broadly understood that to close the equity gap in mAb global access, we need to reach a target cost of $10 per gram of purified, released mAb, a goal long championed by our late colleague, Dr. Steve Hadley, former Senior Program Officer at the Gates Foundation.
- This Grand Challenge is calling for proposals that offer radical, innovative, and technically feasible pathways to achieving the $10/gram target. We invite you to bring your expertise, creativity, and passion to this effort and help shape a future where the best medical treatments are available to everyone, everywhere.
- Applications for proof-of-concept projects (Option A) are due by 11:30 AM. PST on January 31st, 2025. Applications for Option B are due by 11:30 AM. PST on May 31st, 2025.
- Please review the full details for both opportunities on the Grand Challenges website.
- Please contact Jennifer Lidar in Foundation Relations at jlidar@usc.edu if you are interested in applying.
- Monoclonal antibodies are one of the most powerful tools in modern medicine. They are highly specific, safe, and effective medicines for a range of conditions, including treating non-communicable diseases and preventing and treating infectious diseases. These biologic therapies already save lives and improve the quality of life for many millions of patients, but high production costs continue to limit access to mAbs, especially for patients in low- and middle-income settings. While there are indication-specific dosage requirements for mAbs, it is broadly understood that to close the equity gap in mAb global access, we need to reach a target cost of $10 per gram of purified, released mAb, a goal long championed by our late colleague, Dr. Steve Hadley, former Senior Program Officer at the Gates Foundation.
If you are interested in renewing an existing limited submission grant, please contact RII as soon as possible by writing to rii@usc.edu.
Also, if you see a limited submission on our webpage that you wish to submit to, but the internal deadline says “Contact RII,” reach out to rii@usc.edu to submit, as a slot is still available for the call.
Best,
Mike Yarsky (he/him)
Program Specialist | Research Initiatives and Infrastructure
yarsky@usc.edu | https://usc.zoom.us/my/yarsky
University of Southern California
CUB 329 | 3720 S. Flower Street | Los Angeles, CA 90089
Please let us know how we are doing – Take our brief survey!